RGEDF (Chemical Works of Gedeon Richter) Other Stockholders Equity: $126 Mil (As of Dec. 2025)


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.64
GF Value $35.23
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter Other Stockholders Equity?

Chemical Works of Gedeon Richter RGEDF +0.11% 94 Other Stockholders Equity is $126 Mil as of Dec. 2025. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.23 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Chemical Works of Gedeon Richter's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $126 Mil.

Chemical Works of Gedeon Richter's quarterly Other Stockholders Equity declined from Mar. 2025 ($172 Mil) to Jun. 2025 ($166 Mil) and declined from Jun. 2025 ($166 Mil) to Dec. 2025 ($126 Mil).

Chemical Works of Gedeon Richter's annual Other Stockholders Equity increased from Dec. 2023 ($197 Mil) to Dec. 2024 ($261 Mil) but then declined from Dec. 2024 ($261 Mil) to Dec. 2025 ($126 Mil).

Chemical Works of Gedeon Richter Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter Other Stockholders Equity Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.28 165.72 196.91 260.82 126.36

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.80 260.82 171.74 166.12 126.36
RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $126 Mil mean?
Chemical Works of Gedeon Richter (RGEDF) has a Other Stockholders Equity of $126 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chemical Works of Gedeon Richter and its competitors.
Is Chemical Works of Gedeon Richter's Other Stockholders Equity too high?
Chemical Works of Gedeon Richter's current Other Stockholders Equity is $126 Mil. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's Other Stockholders Equity compare to ZTS and UTHR?
Chemical Works of Gedeon Richter's Other Stockholders Equity of $126 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Chemical Works of Gedeon Richter and its competitors. Chemical Works of Gedeon Richter's current Other Stockholders Equity is $126 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.23, compared to a current price of $39.64 — trading 12.5% above its estimated fair value. The current Other Stockholders Equity is $126 Mil. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current Other Stockholders Equity is $126 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.64 is trading 12.5% above its estimated GF Value™ of $35.23. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • Other Stockholders Equity: $126 Mil
  • GF Value™: $35.23 vs. price of $39.64 (12.5% above fair value)
  • GF Score™: 94/100 with 5 warning signs

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.64
Price
$35.23
GF Value